Self Addiction Severity Index Via Phone and Internet

说明(由申请人提供)：我们建议(1)将 互联网/内联网的自管成瘾严重指数(SA-ASI) (“网络”)技术和交互式语音应答(IVR)技术。我们会 然后(2)通过1VR和网络软件对仪器进行验证 临床医生在130例随机试验中应用ASI的黄金标准 临床环境中的受试者。在研究期间，临床医生将收到 来自临床医生管理的ASI结果的自动打印报告 (CA-ASI)。这笔第一阶段的赠款将导致开发和验证 三个不同的产品：(1)网络软件版本 临床医生管理的ASI(CA-ASI)，(2)SA-ASI的网络软件版本， 以及(3)对变化敏感的SA-ASI部分的IVR版本 (SA-ASI-CURRENT)，并且适合在IVR系统上使用以跟踪结果 远程的。所有这三种产品都将生成自动报告。建议数 软件和新版本的ASI将有助于改善成瘾管理和 在全国范围内跟踪结果。除了其他好处外，拟议的研究 产品应该：(1)增加获得低成本ASIS的机会，(2)促进研究 通过广泛使用廉价、标准化的评估和结果 以及(3)帮助改善药物滥用的临床护理 精神错乱。 建议的商业应用： 这个项目的第一阶段将开发和验证(1)基于互联网的全面临床医生管理的ASI，(2)基于互联网的自我管理的全面ASI，(3)基于自动电话IVR的自我管理的ASI(仅对变化敏感的项目)，以及(4)所有三种产品的相关电子临床报告。

DESCRIPTION (provided by applicant): We propose (1) to adapt the Self-Administered Addiction Severity Index (SA-ASI) to both Internet/lntranet ("Net") technology and Interactive Voice Response (IVR) technology. We will then (2) validate the instrument administered via 1VR and Net software against the gold standard, clinician-administered ASI in a randomized trial on 130 subjects in a clinical setting. During the study, clinicians will receive automated, printed reports on results from the clinician-administered ASI (CA-ASI). This Phase I grant will result in the development and validation of three distinct products: (1) a Net software version of the clinician-administered ASI (CA-ASI), (2) a Net software version of the SA-ASI, and (3) an IVR version of the portion of the SA-ASI that is sensitive to change (SA-ASI-Current) and suitable for using on an IVR system to track outcomes remotely. All three products will generate automated reports. The proposed software and new versions of the ASI will help improve addiction management and outcomes tracking across the country. Among other benefits, the proposed study and products should: (1) increase access to low-cost ASIs, (2) promote research through widespread use of an inexpensive, standardized assessment and outcomes tracking instrument, and (3) help improve clinical care for substance abuse disorders. PROPOSED COMMERCIAL APPLICATION: The Phase I portion of this project will result in development and validation of (1) an internet based full clinician administered ASI, (2) an internet based self-administered full ASI, (3) an automated telephone IVR based self-administered ASI (Items sensitive to change only), and (4) associated electronic clinical reports for all 3 products.